Gastric balloon maker to go public via a SPAC run by former Medtronic CEO

Dow Jones2023-02-09

MW Gastric balloon maker to go public via a SPAC run by former Medtronic CEO

Allurion Technologies Inc., which makes a gastric balloon that can be used for weight loss, plans to go public through an agreement with Compute Health Acquisition Corp. $(CPUH)$, a special purpose acquisition company run by former Medtronic $(MDT)$ CEO Omar Ishrak. The combined company will trade under the new ticker, ALUR, and the proposed deal includes a financing agreement with RTW Investments. Allurion said it has treated more than 100,000 patients worldwide with its technology and an accompanying behavior change program, with one study finding that patients lost about 14% of their body weight. The company had $64 million in revenue in 2022, up from $38 million in 2021. Once the deal closes, Allurion will have a pro forma enterprise value of $500 million, and it will receive $87 million in gross cash proceeds. The deal is expected to close in the first half of the year.

-Jaimy Lee

 

(END) Dow Jones Newswires

February 09, 2023 08:57 ET (13:57 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment